WallStSmart
NTRA

Natera Inc

NASDAQ: NTRA · HEALTHCARE · DIAGNOSTICS & RESEARCH

$199.14
-3.06% today

Updated 2026-06-05

Market cap
$30.37B
P/E ratio
P/S ratio
12.14x
EPS (TTM)
$-1.61
Dividend yield
52W range
$132 – $256
Volume
1.5M

Natera Inc (NTRA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20122013201420152016201720182019202020212022202320242025
Operating cash flow$-14.90M$-24.13M$10.49M$-37.83M$-74.05M$-97.83M$-70.58M$-63.44M$-182.51M$-335.24M$-431.50M$-246.96M$135.66M$215.30M
Capital expenditures$4.59M$8.24M$9.96M$7.85M$23.14M$9.87M$3.88M$4.97M$19.60M$41.03M$47.70M$39.20M$66.42M$106.19M
Depreciation
Stock-based comp$605000.00$1.66M$5.16M$7.33M$10.60M$11.40M$14.20M$28.62M$50.17M$115.22M$152.38M$191.81M$274.43M$354.40M
Free cash flow$-19.49M$-32.38M$533000.00$-45.68M$-97.19M$-107.69M$-74.46M$-68.41M$-202.12M$-376.27M$-479.20M$-286.15M$69.24M$109.11M
Investing cash flow
Financing cash flow
Dividends paid$0.00$2.59M$0.00$7.11M$30.00M
Share repurchases
Debt repayment
Net change in cash$-58.23M$-13.69M$-2.64M$37.98M$10.98M$-13.13M$35.76M$381.48M

Frequently asked questions

What is Natera Inc's revenue?

Natera Inc's trailing twelve-month revenue is $2.50B, and consensus projects about $6.49B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is NTRA?

In its most recent fiscal year, NTRA ran a gross margin of 64.85%, an operating margin of -13.44%, and a net margin of -9.03%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does NTRA generate?

NTRA produced $109.11M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NTRA's balance sheet healthy?

NTRA holds $1.08B in cash and equivalents against — in long-term debt, on $1.71B of shareholder equity. That debt is best read against the cash flow the business throws off each year.